Answers are grounded in this paper and cite their sources.
Objective: Systemic inflammation and malnutrition are critical determinants of mortality in hemodialysis patients. The C-reactive protein/albumin ratio (CAR) integrates these two pathways. This study aimed to assess the prognostic value of CAR for all-cause mortality in maintenance hemodialysis patients and compare it with other inflammatory biomarkers. Methods: This multicenter retrospective study included 204 hemodialysis patients followed between January 2022 and January 2024. Patients were stratified into survivor ( n = 161) and non-survivor ( n = 43) groups. Demographic data and inflammatory biomarkers, including CAR, neutrophil/lymphocyte ratio (NLR), and systemic immune-inflammation index (SII), were analyzed. Multivariate logistic regression was used to identify independent predictors of mortality. Results: Non-survivors exhibited significantly higher median CAR levels (3.86 vs 1.72, p < 0.001) and lower Kt/V values compared to survivors. In ROC analysis, 6-month average Kt/V (AUC = 0.764) and RAR (AUC = 0.751) showed high discriminatory power, followed by CAR (AUC = 0.715). However, in multivariate regression, high CAR (>2.59) remained a robust independent predictor of mortality (odds ratio: 3.61, p = 0.002), alongside age and Kt/V, whereas RDW lost its significance. Conclusions: CAR may serve as a simple, cost-effective, and independent prognostic marker for all-cause mortality in hemodialysis patients. While dialysis adequacy (Kt/V) remains the dominant predictor, integrating CAR into routine monitoring has the potential to enhance risk stratification by capturing the malnutrition-inflammation burden, pending validation in future prospective cohorts.
No takes yet. Share an insight, caveat, or question.
Aydin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: